MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment
January 09, 2024 09:00 AM Eastern Standard Time MENLO PARK, Calif. & LAUSANNE, Switzerland–(BUSINESS WIRE)–MedaSystems, a pioneer in software to provide access to pre-approval medicine, is pleased to announce additional funding from Debiopharm Innovation Fund, the…